On a somber morning in Beijing, the gates of the Babaoshan Revolutionary Cemetery saw an outpouring of grief that exceeded all expectations. Hundreds of China’s most prominent financiers, academics, and former central bankers gathered to bid farewell to Dr. Gao Shanwen, who passed away at the age of 55. The relocation of his memorial service to a larger hall reflected not just his popularity, but his status as the primary architect of modern Chinese sell-side macro-research.
Gao’s journey was emblematic of the meritocratic rise of China’s intellectual elite. A son of a humble family from Shanxi, he transitioned from studying wireless electronics at Peking University to economics, eventually earning a doctorate under the tutelage of former PBoC Governor Zhou Xiaochuan. His career trajectory—moving from the inner sanctum of the central bank to the competitive world of securities—mirrored the liberalization of the Chinese financial system over the past three decades.
He is perhaps best known for his 'Asset Revaluation Theory,' formulated in 2006. By looking beyond simple supply and demand to examine the asset allocation behaviors of households and firms, Gao accurately predicted the historic surge of the Shanghai Composite Index toward its 6000-point peak. This framework transformed macro-research from a dry recitation of government policy into a practical, data-driven discipline for asset allocation, earning him the nickname 'the textbook for macro-analysts.'
Despite his commercial success at Everbright and later SDIC Securities, Gao maintained a rare intellectual integrity. In 2012, he famously withdrew from industry popularity rankings, arguing that the pursuit of fame through 'roadshow PR' was yielding diminishing returns. He preferred to focus on deep-dive research, even when his later findings—such as his 'Keep 4, Strive for 5' growth prediction in 2019—challenged the prevailing optimism of the time.
In his final months, Gao approached his battle with T-cell lymphoma with the same analytical rigor that defined his career. He did not merely follow doctor's orders; he researched global clinical trials, compared treatment paths from Hong Kong to Beijing, and actively participated in the design of his own medical protocols. His public documentation of this journey offered a final masterclass in the rationalist philosophy he championed throughout his life.
The death of Gao Shanwen also marks a tragic milestone for a specific generation of Peking University alumni. He is the third major figure from his cohort to pass away prematurely in the last five years, following value-investing pioneer Wang Guobin and brokerage leader Li Yong. Their collective loss highlights the immense pressure and physical toll exacted on the pioneers who built China’s capital markets from the ground up.